| MolName | (E)-N-[[[2-(5-morpholin-4-yltetrazol-2-yl)acetyl]amino]carbamothioyl]-3-phenylprop-2-enamide |
| MolecularFormula | C17H20N8O3S |
| Smiles | O=C(Cn1nnc(N2CCOCC2)n1)NNC(NC(/C=C/c1ccccc1)=O)=S |
| InChI | InChI=1S/C17H20N8O3S/c26-14(7-6-13-4-2-1-3-5-13)18-17(29)21-19-15(27)12-25-22-16(20-23-25)24-8-10-28-11-9-24/h1-7H,8-12H2,(H,19,27)(H2,18,21,26,29) |
| InChIK | XRJZDZLQWAVFHA-UHFFFAOYSA-N |
| TotalMolweight | 416.465 |
| Molweight | 416.465 |
| MonoisotopicMass | 416.137907 |
| CLogP | -0.164 |
| CLogS | -2.522 |
| H Acceptors | 11 |
| H Donors | 3 |
| TotalSurfaceArea | 323.19 |
| Relative PSA | 0.43872 |
| PolarSurfaceArea | 158.39 |
| Druglikeness | -0.71639 |
| Mutagenic | high |
| Tumorigenic | none |
| Reproductive Effective | high |
| Irritant | none |
| Nasty Functions | thio-amide/urea |
| Shape Index | 0.68966 |
| Fragments | 1 |
| Non HAtoms | 29 |
| NonCHAtoms | 12 |
| Electronegative Atoms | 12 |
| Rotatable Bond | 6 |
| Rings Closures | 3 |
| Small Rings | 3 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 11 |
| Sp3Atoms | 7 |
| Symmetricatoms | 4 |
| Amides | 1 |
| Aromatic Nitrogens | 4 |
| StereoCon |
Click to Load Molecule:
1 - (E)-N-[[[2-(5-morpholin-4-yltetrazol-2-yl)acetyl]amino]carbamothioyl]-3-phenylprop-2-enamide | 2 - (E)-N-[[[2-(5-morpholin-4-yltetrazol-2-yl)acetyl]amino]carbamothioyl]-3-phenylprop-2-enamide